| 30/09/26 | 13:00:00 | 30 Sept 2026 | | Interim Results for the Six Months to June 30, 2026, and Business Update | GNW |
| 25/09/26 | 07:00:00 | 25 Sept 2026 | | The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer | GNW |
| 16/09/26 | 16:00:00 | 16 Sept 2026 | | Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial | GNW |
| 14/09/26 | 07:00:00 | 14 Sept 2026 | | Avacta Appoints Mats Blom to the Board of Directors as Chair of Audit Committee | GNW |
| 08/07/26 | 07:00:00 | 8 Jul 2026 | | Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors | GNW |
| 01/06/26 | 07:00:00 | 1 Jun 2026 | | Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026 | GNW |
| 19/05/26 | 07:14:00 | 19 May 2026 | | Unaudited Preliminary Results for the Year Ended December 31, 2025 | GNW |
| 06/05/26 | 07:00:00 | 6 May 2026 | | Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026 | GNW |
| 21/04/26 | 17:00:00 | 21 Apr 2026 | | Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform | GNW |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | | Statement regarding market speculation | RNS |
| 08/06/23 | 07:00:05 | 8 Jun 2023 | | AGM and Shareholder Event Detailed Agenda | RNS |
| 05/06/23 | 07:00:04 | 5 Jun 2023 | | Second Milestone in AffyXell Joint Venture | RNS |
| 02/06/23 | 07:00:06 | 2 Jun 2023 | | Posting of Annual Report and Notice of AGM | RNS |
| 01/06/23 | 07:00:10 | 1 Jun 2023 | | Avacta acquires Coris Bioconcept | RNS |
| 27/04/23 | 07:00:08 | 27 Apr 2023 | | Block Listing Six Monthly Return | RNS |
| 27/04/23 | 07:00:06 | 27 Apr 2023 | | First Patient Dosed in the US in AVA6000 Phase 1 | RNS |
| 25/04/23 | 07:00:09 | 25 Apr 2023 | | Preliminary Results | RNS |
| 21/04/23 | 14:49:02 | 21 Apr 2023 | | Issue of Equity and Total Voting Rights | RNS |
| 17/04/23 | 07:00:05 | 17 Apr 2023 | | AVA3996 data poster presented at AACR | RNS |
| 06/04/23 | 07:00:04 | 6 Apr 2023 | | 1st US Clinical Investigator AVA6000 Sites Opened | RNS |
| 05/04/23 | 07:00:03 | 5 Apr 2023 | | First Patient Dosed in Fifth Cohort of AVA6000 | RNS |
| 03/04/23 | 07:00:17 | 3 Apr 2023 | | Notice of Results and Investor Presentation | RNS |
| 27/03/23 | 07:00:04 | 27 Mar 2023 | | AVA3996 data poster presentation at AACR | RNS |
| 13/03/23 | 07:00:07 | 13 Mar 2023 | | Statement re: Silicon Valley Bank | RNS |
| 23/02/23 | 07:00:07 | 23 Feb 2023 | | Avacta Therapeutics Division Science Day | RNS |
| 13/02/23 | 07:00:05 | 13 Feb 2023 | | Issue of Equity and Total Voting Rights | RNS |
| 23/01/23 | 12:20:14 | 23 Jan 2023 | | Issue of Equity and Total Voting Rights | RNS |
| 17/01/23 | 14:05:46 | 17 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 17/01/23 | 14:00:24 | 17 Jan 2023 | | Price Monitoring Extension | RNS |
| 17/01/23 | 11:05:44 | 17 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 17/01/23 | 11:00:34 | 17 Jan 2023 | | Price Monitoring Extension | RNS |
| 17/01/23 | 09:05:36 | 17 Jan 2023 | | Second Price Monitoring Extn | RNS |
| 17/01/23 | 09:00:09 | 17 Jan 2023 | | Price Monitoring Extension | RNS |
| 17/01/23 | 07:00:05 | 17 Jan 2023 | | Successful Completion of Fourth Dose Escalation | RNS |
| 16/01/23 | 10:15:56 | 16 Jan 2023 | | Block Listing Application to AIM | RNS |
| 19/12/22 | 07:00:07 | 19 Dec 2022 | | Avacta to Host Therapeutics Division Science Day | RNS |
| 08/11/22 | 07:01:01 | 8 Nov 2022 | | Director/PDMR Shareholding | RNS |
| 08/11/22 | 07:00:04 | 8 Nov 2022 | | Result of the Open Offer | RNS |
| 31/10/22 | 13:32:24 | 31 Oct 2022 | | Avacta to Present at Theranostics FAP Summit | RNS |
| 31/10/22 | 11:05:35 | 31 Oct 2022 | | Second Price Monitoring Extn | RNS |
| 31/10/22 | 11:00:24 | 31 Oct 2022 | | Price Monitoring Extension | RNS |
| 28/10/22 | 07:00:07 | 28 Oct 2022 | | Block Listing Six Monthly Return | RNS |
| 20/10/22 | 08:01:03 | 20 Oct 2022 | | Director/PDMR Shareholding | RNS |
| 20/10/22 | 08:01:01 | 20 Oct 2022 | | Admission of the Company’s Ordinary Shares | RNS |
| 20/10/22 | 07:00:05 | 20 Oct 2022 | | Posting of the Company’s Open Offer Circular | RNS |
| 18/10/22 | 11:49:01 | 18 Oct 2022 | | Result of Placing | RNS |
| 18/10/22 | 09:16:20 | 18 Oct 2022 | | Private CB and ABB Launch | RNS |
| 18/10/22 | 09:14:08 | 18 Oct 2022 | | Proposed acquisition of Launch Diagnostics | RNS |
| 29/09/22 | 07:00:11 | 29 Sept 2022 | | Interim Results for the Period Ended 30 June 2022 | RNS |
| 26/09/22 | 07:00:14 | 26 Sept 2022 | | Notice of Results | RNS |
